Investor Group Urges Stockholders of Pasithea Therapeutics to Vote to Call Special Meeting
The Investor Group comprising Camac Partners, Concord Investment Partners, and Leonite Capital, significant stockholders of Pasithea Therapeutics Corp. (NASDAQ: KTTA), announced their intention to call a Special Meeting of Stockholders.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
--Near Threshold Required, Every Vote Matters--
Dear Pasithea Stockholders,
As you know, we are seeking to call a Special Meeting of Stockholders at Pasithea for a simple reason: we have lost all confidence in the incumbent Board of Directors to be effective and prudent stewards of our capital. Each of us are substantial investors in Pasithea, and we don’t want to see that investment squandered by directors who are more interested in taking care of themselves and their hand-picked allies than stockholders.
We have been pleased with the high degree of investor engagement and support we have received thus far, such that we are close to the threshold needed to call the special meeting. But EVERY VOTE COUNTS. If you have not returned your proxy card in support of our efforts, please do so immediately, either by reaching us directly or through InvestorCom, whose contact information is below. Thank you!
View source version on businesswire.com: https://www.businesswire.com/news/home/20220824005224/en/
For Investors:
info@investor-com.com
Source: